Ordinary Rebalance | Solactive Diversified Developed Economy Healthcare Index | Effective Date 2nd November 2023
In the ordinary rebalance, the following composition will be implemented effective open 02.11.2023:
| ABBOTT LABORATORIES |
| ABBVIE INC |
| AMGEN INC |
| ASTRAZENECA PLC |
| BAYER AG |
| BECTON DICKINSON AND CO |
| BRISTOL-MYERS SQUIBB CO |
| CRISPR THERAPEUTICS AG |
| DANAHER CORP |
| ELI LILLY & CO |
| ESSILORLUXOTTICA |
| GILEAD SCIENCES INC |
| HOLOGIC INC |
| JOHNSON & JOHNSON |
| MEDTRONIC PLC |
| MERCK & CO. INC. |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| PFIZER INC |
| REGENERON PHARMACEUTICALS |
| ROCHE HOLDING AG |
| SANOFI SA |
| SIEMENS HEALTHINEERS AG |
| SMITH & NEPHEW PLC |
| STRYKER CORP |
| THERMO FISHER SCIENTIFIC INC |
| UNITEDHEALTH GROUP INC |
| VERTEX PHARMACEUTICALS INC |
| ZIMMER BIOMET HOLDINGS INC |
| ZOETIS INC |